06826.HK
Shanghai Haohai Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 15.20
−5.65%Margins
Gross margin
65.2%
EBITDA margin
8.2%
EBIT margin
-1.6%
Net margin
6.2%
FCF margin
11.2%
2.7%
Return on equity
2.2%
Return on assets
-0.7%
Return on invested capital
0.35x
Asset turnover
HKD 582.8M
Cash from operations
HKD 12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026